Related Experiment Video
Updated: Nov 2, 2025
03:50
Author Spotlight: Effectiveness of Extracorporeal Shockwave Therapy in Achilles Tendinopathy Treatment
Published on: August 2, 2024
1.5K
Use of Shockwave Lithoplasty for a Patient With Recurrent Angina
Sabah Siddiqui1, Sergey Ayzenberg1, Ahmad Morshed1
1Cardiology, Maimonides Medical Center, Brooklyn, USA.
Cureus
|June 14, 2021
Summary
Shockwave intravascular lithoplasty (S-IVL) effectively treats severe coronary artery calcification, offering a promising alternative to current methods. This technique modifies plaque with reduced risk of vascular trauma, improving patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Devices
Background:
- Current treatments for intimal calcium burden have limited success and carry risks.
- Severe calcification and in-stent restenosis pose challenges in coronary artery disease management.
Observation:
- A 59-year-old male with coronary artery disease presented with angina and severe in-stent restenosis in the mid-right coronary artery.
- The restenosis was characterized by under-expansion and severe calcification, necessitating plaque modification.
Findings:
- Shockwave intravascular lithoplasty (S-IVL) was employed to reduce the calcium burden in the severely calcified coronary lesion.
- S-IVL demonstrated effectiveness in plaque modification for this complex case.
Implications:
- S-IVL presents a promising technique for treating severely calcified coronary lesions.
- This approach may offer reduced risks of myocardial injury and mechanical vascular trauma compared to existing therapies.
- Tailoring treatment to individual patient and lesion characteristics is crucial for optimal results.
Related Concept Videos
01:26Angina IV: Management
88
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
88
01:27Peripheral Artery Disease III: Interprofessional Care
89
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
89
01:20Angina V: Nursing Management
112
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
112
01:27Coronary Artery Disease V: Interprofessional Care
84
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
84
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
869
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
869
01:27Angina II: Classification
84
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
84